Vascular dysfunction in obesity and insulin resistance
1Center for Interdisciplinary Research in Cardiovascular Sciences, Department of Physiology and Pharmacology, West Virginia University School of Medicine, Morgantown, West Virginia 26505, USA. jfrisbee@hsc.wvu.edu
Summary
Obesity and impaired glycemic control increase vascular disease risk. This special issue reviews how these conditions, along with insulin resistance, cause microvascular dysfunction and impact organ health.
Area of Science:
- Cardiovascular Science
- Metabolic Disease Research
- Vascular Biology
Background:
- Obesity and impaired glycemic control are rising health concerns.
- These conditions are strongly linked to an increased risk of vascular disease.
- Understanding the mechanistic basis of these relationships is crucial.
Purpose of the Study:
- To summarize current knowledge on obesity, insulin resistance, and vascular dysfunction.
- To highlight research on the functional outcomes of these interconnected conditions.
- To provide a basis for future investigations into microvasculopathy.
Main Methods:
- This issue compiles a series of review articles.
- Expert authors synthesize existing research findings.
- Key topics include blood flow, vascular reactivity, and organ-specific circulations.
Main Results:
- Altered blood flow regulation, vascular reactivity, and mechanics are discussed.
- Impacts on coronary, renal, and hepatic circulations are detailed.
- The roles of inflammation, endothelial permeability, and perivascular adipose tissue are examined.
Conclusions:
- Obesity and insulin resistance significantly contribute to microvascular dysfunction.
- These metabolic disturbances are key elements in the development of systemic pathologies.
- Further research is needed to fully understand and address microvasculopathy.
More Related Videos
Related Concept Videos
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...


